Managing stroke and bleeding with LVAD patients

Interviewed by Steven Greer, MD

August 2, 2010- As continuous flow pump LVAD devices are being implanted for longer periods of time in destination therapy indications, such as with Dick Cheney, unique problems of hypertensive stroke and bleeding need to be prevented. Dr. Slaughter explains how.

Update November 26, 2013- The NEJM published an abstract from the Cleveland Clinic that reports much higher rates of pump thrombosis in the HeartMate 2. The New York Times wrote about it.

 

Mark Slaughter, MD: the HeartMate 2 trial

Dr. Slaughter, Chief of Cardiothoracic Surgery at Louisville, discusses the new Thoratec HeartMate II destination therapy data presented at the AHA 2009 meeting.